River Global Investors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$881K Sell
9,535
-7,892
-45% -$711K 0.17% 110
2024
Q3
$1.46M Buy
17,427
+672
+4% +$51.3K 0.31% 98
2024
Q2
$1.15M Sell
16,755
-236
-1% -$15.7K 0.32% 111
2024
Q1
$1.24M Sell
16,991
-191
-1% -$14.7K 0.31% 111
2023
Q4
$1.39M Sell
17,182
-158
-0.9% -$12.3K 0.26% 119
2023
Q3
$1.3M Sell
17,340
-1,909
-10% -$147K 0.3% 96
2023
Q2
$1.48M Sell
19,249
-240
-1% -$19.1K 0.29% 104
2023
Q1
$1.62M Sell
19,489
-750
-4% -$62.1K 0.33% 98
2022
Q4
$1.74M Buy
20,239
+137
+0.7% +$10.8K 0.37% 93
2022
Q3
$1.24M Sell
20,102
-2,190
-10% -$138K 0.24% 112
2022
Q2
$1.38M Sell
22,292
-4,113
-16% -$255K 0.24% 113
2022
Q1
$1.57M Buy
26,405
+3,820
+17% +$244K 0.21% 123
2021
Q4
$1.64M Buy
22,585
+400
+2% +$27.6K 0.13% 121
2021
Q3
$1.55M Hold
22,185
0.12% 117
2021
Q2
$1.52M Hold
22,185
0.1% 113
2021
Q1
$1.43M Sell
22,185
-34,305
-61% -$2.21M 0.09% 114
2020
Q4
$3.29M Sell
56,490
-6,450
-10% -$389K 0.19% 93
2020
Q3
$3.98M Sell
62,940
-2,020
-3% -$140K 0.29% 94
2020
Q2
$5M Buy
64,960
+830
+1% +$63.6K 0.37% 84
2020
Q1
$4.79M Buy
+64,130
New +$4.43M 0.44% 65
2017
Q2
Sell
-12,559
Closed -$853K 104
2017
Q1
$853K Buy
+12,559
New +$883K 0.19% 97
2016
Q4
Sell
-13,300
Closed -$1.05M 89
2016
Q3
$1.05M Buy
+13,300
New +$1.08M 0.33% 86

Other funds holding GILD

River Global Investors's GILD Position: Q4 2024 in Review

River Global Investors reduced its Gilead Sciences (GILD) stake by 45% in Q4 2024, selling an estimated $711K and leaving 9,535 shares worth $881K. The position accounts for 0.17% of the portfolio, ranked #110.

River Global Investors first reported a position in GILD in Q3 2016 and has held it in 22 quarters since. The position peaked at $5M in Q2 2020. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • River Global Investors held 9,535 shares of Gilead Sciences worth $881K as of Q4 2024.
  • River Global Investors sold 7,892 Gilead Sciences shares in Q4 2024, an estimated $711K.
  • Gilead Sciences made up 0.17% of River Global Investors's portfolio in Q4 2024, its #110 holding.
  • River Global Investors first reported a position in Gilead Sciences in Q3 2016 and has held it in 22 quarters since.
  • River Global Investors's Gilead Sciences position peaked at $5M in Q2 2020.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on River Global Investors's 13F filing for Q4 2024, filed 7 Feb 2025.